173 related articles for article (PubMed ID: 21838549)
1. Adaptive trial designs.
Lai TL; Lavori PW; Shih MC
Annu Rev Pharmacol Toxicol; 2012; 52():101-10. PubMed ID: 21838549
[TBL] [Abstract][Full Text] [Related]
2. Adaptive design of confirmatory trials: Advances and challenges.
Lai TL; Lavori PW; Tsang KW
Contemp Clin Trials; 2015 Nov; 45(Pt A):93-102. PubMed ID: 26079372
[TBL] [Abstract][Full Text] [Related]
3. Adaptive designs in critical care trials: a simulation study.
Li W; Cornelius V; Finfer S; Venkatesh B; Billot L
BMC Med Res Methodol; 2023 Oct; 23(1):236. PubMed ID: 37853343
[TBL] [Abstract][Full Text] [Related]
4. Adaptive designs: The Swiss Army knife among clinical trial designs?
Bretz F; Gallo P; Maurer W
Clin Trials; 2017 Oct; 14(5):417-424. PubMed ID: 28982262
[TBL] [Abstract][Full Text] [Related]
5. Do we need to adjust for interim analyses in a Bayesian adaptive trial design?
Ryan EG; Brock K; Gates S; Slade D
BMC Med Res Methodol; 2020 Jun; 20(1):150. PubMed ID: 32522284
[TBL] [Abstract][Full Text] [Related]
6. An evaluation of inferential procedures for adaptive clinical trial designs with pre-specified rules for modifying the sample size.
Levin GP; Emerson SC; Emerson SS
Biometrics; 2014 Sep; 70(3):556-67. PubMed ID: 24766094
[TBL] [Abstract][Full Text] [Related]
7. Using Bayesian adaptive designs to improve phase III trials: a respiratory care example.
Ryan EG; Bruce J; Metcalfe AJ; Stallard N; Lamb SE; Viele K; Young D; Gates S
BMC Med Res Methodol; 2019 May; 19(1):99. PubMed ID: 31088354
[TBL] [Abstract][Full Text] [Related]
8. Bayesian hierarchical modeling of patient subpopulations: efficient designs of Phase II oncology clinical trials.
Berry SM; Broglio KR; Groshen S; Berry DA
Clin Trials; 2013 Oct; 10(5):720-34. PubMed ID: 23983156
[TBL] [Abstract][Full Text] [Related]
9. Bayesian adaptive design for pediatric clinical trials incorporating a community of prior beliefs.
Wang Y; Travis J; Gajewski B
BMC Med Res Methodol; 2022 Apr; 22(1):118. PubMed ID: 35448963
[TBL] [Abstract][Full Text] [Related]
10. Practical guidelines for adaptive seamless phase II/III clinical trials that use Bayesian methods.
Kimani PK; Glimm E; Maurer W; Hutton JL; Stallard N
Stat Med; 2012 Aug; 31(19):2068-85. PubMed ID: 22437262
[TBL] [Abstract][Full Text] [Related]
11. Adaptive blinded sample size adjustment for comparing two normal means--a mostly Bayesian approach.
Hartley AM
Pharm Stat; 2012; 11(3):230-40. PubMed ID: 22422722
[TBL] [Abstract][Full Text] [Related]
12. Alternative models and randomization techniques for Bayesian response-adaptive randomization with binary outcomes.
Proper J; Connett J; Murray T
Clin Trials; 2021 Aug; 18(4):417-426. PubMed ID: 33926267
[TBL] [Abstract][Full Text] [Related]
13. Adaptive designs from a Data Safety Monitoring Board perspective: Some controversies and some case studies.
Turnbull BW
Clin Trials; 2017 Oct; 14(5):462-469. PubMed ID: 28178849
[TBL] [Abstract][Full Text] [Related]
14. Sample size adjustment based on promising interim results and its application in confirmatory clinical trials.
Chen YH; Li C; Lan KK
Clin Trials; 2015 Dec; 12(6):584-95. PubMed ID: 26195615
[TBL] [Abstract][Full Text] [Related]
15. Flexible designs by adaptive plans of generalized Pocock- and O'Brien-Fleming-type and by self-designing clinical trials.
Hartung J
Biom J; 2006 Aug; 48(4):521-36. PubMed ID: 16972703
[TBL] [Abstract][Full Text] [Related]
16. Adaptive methods: when and how should they be used in clinical trials?
Porcher R; Lecocq B; Vray M;
Therapie; 2011; 66(4):319-26, 309-17. PubMed ID: 21851793
[TBL] [Abstract][Full Text] [Related]
17. Using Bayesian statistics in confirmatory clinical trials in the regulatory setting: a tutorial review.
Lee SY
BMC Med Res Methodol; 2024 May; 24(1):110. PubMed ID: 38714936
[TBL] [Abstract][Full Text] [Related]
18. On sample size determination in multi-armed confirmatory adaptive designs.
Wassmer G
J Biopharm Stat; 2011 Jul; 21(4):802-17. PubMed ID: 21516570
[TBL] [Abstract][Full Text] [Related]
19. On efficient two-stage adaptive designs for clinical trials with sample size adjustment.
Liu Q; Li G; Anderson KM; Lim P
J Biopharm Stat; 2012; 22(4):617-40. PubMed ID: 22651105
[TBL] [Abstract][Full Text] [Related]
20. Adaptive Designs with Discrete Test Statistics and Consideration of Overrunning.
Schmidt R; Burkhardt B; Faldum A
Methods Inf Med; 2015; 54(5):434-46. PubMed ID: 26429500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
